Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
BMC Complement Altern Med ; 18(1): 38, 2018 Jan 30.
Artículo en Inglés | MEDLINE | ID: mdl-29382326

RESUMEN

BACKGROUND: Recent studies have found that plant derived microRNA can cross-kingdom regulate the expression of genes in humans and other mammals, thereby resisting diseases. Can exogenous miRNAs cross the blood-prostate barrier and entry prostate then participate in prostate disease treatment? METHODS: Using HiSeq sequencing and RT-qPCR technology, we detected plant miRNAs that enriched in the prostates of rats among the normal group, BPH model group and rape bee pollen group. To forecast the functions of these miRNAs, the psRobot software and TargetFinder software were used to predict their candidate target genes in rat genome. The qRT-PCR technology was used to validate the expression of candidate target genes. RESULTS: Plant miR5338 was enriched in the posterior lobes of prostate gland of rats fed with rape bee pollen, which was accompanied by the improvement of BPH. Among the predicted target genes of miR5338, Mfn1 was significantly lower in posterior lobes of prostates of rats in the rape bee pollen group than control groups. Further experiments suggested that Mfn1 was highly related to BPH. CONCLUSIONS: These results suggesting that plant-derived miR5338 may involve in treatment of rat BPH through inhibiting Mfn1 in prostate. These results will provide more evidence for plant miRNAs cross-kingdom regulation of animal gene, and will provide preliminary theoretical and experimental basis for development of rape bee pollen into innovative health care product or medicine for the treatment of BPH.


Asunto(s)
Proteínas de la Membrana/antagonistas & inhibidores , MicroARNs/farmacología , Proteínas Mitocondriales/antagonistas & inhibidores , Polen , Próstata/efectos de los fármacos , Hiperplasia Prostática/metabolismo , ARN de Planta/farmacología , Animales , Abejas , Peso Corporal/efectos de los fármacos , Masculino , Proteínas de la Membrana/metabolismo , Proteínas Mitocondriales/metabolismo , Tamaño de los Órganos/efectos de los fármacos , ARN de Planta/farmacocinética , Ratas
2.
Mol Nutr Food Res ; 59(10): 1962-72, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26147655

RESUMEN

SCOPE: The "dietary xenomiR hypothesis" proposes that microRNAs (miRNAs) in foodstuffs survive transit through the mammalian gastrointestinal tract and pass into cells intact to affect gene regulation. However, debate continues as to whether dietary intake poses a feasible route for such exogenous gene regulators. Understanding on miRNA levels during pretreatments of human diet is essential to test their bioavailability during digestion. This study makes the novel first use of an in vitro method to eliminate the inherent complexities and variability of in vivo approaches used to test this hypothesis. METHODS AND RESULTS: Plant miRNA levels in soybean and rice were measured during storage, processing, cooking, and early digestion using real-time PCR. We have demonstrated for the first time that storage, processing, and cooking does not abolish the plant miRNAs present in the foodstuffs. In addition, utilizing a simulated human digestion system revealed significant plant miRNA bioavailability after early stage digestion for 75 min. Attenuation of plant messenger RNA and synthetic miRNA was observed under these conditions. CONCLUSION: Even after an extensive pretreatment, plant-derived miRNA, delivered by typical dietary ingestion, has a robustness that could make them bioavailable for uptake during early digestion. The potential benefit of these regulatory molecules in pharma nutrition could be explored further.


Asunto(s)
Digestión , Glycine max/genética , MicroARNs/farmacocinética , Oryza/genética , ARN de Planta/farmacocinética , Disponibilidad Biológica , Culinaria , Calor , Humanos , MicroARNs/química , ARN de Planta/química , Reacción en Cadena en Tiempo Real de la Polimerasa , Ribonucleasas/química
3.
Cell Res ; 25(1): 39-49, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25287280

RESUMEN

Influenza A viruses (IAVs), particularly H1N1, H5N1 and H7N9, pose a substantial threat to public health worldwide. Here, we report that MIR2911, a honeysuckle (HS)-encoded atypical microRNA, directly targets IAVs with a broad spectrum. MIR2911 is highly stable in HS decoction, and continuous drinking or gavage feeding of HS decoction leads to a significant elevation of the MIR2911 level in mouse peripheral blood and lung. Bioinformatics prediction and a luciferase reporter assay showed that MIR2911 could target various IAVs, including H1N1, H5N1 and H7N9. Synthetic MIR2911 significantly inhibited H1N1-encoded PB2 and NS1 protein expression, but did not affect mutants in which the MIR2911-binding nucleotide sequences were altered. Synthetic MIR2911, extracted RNA from HS decoction and HS decoction all significantly inhibited H1N1 viral replication and rescued viral infection-induced mouse weight loss, but did not affect infection with a mutant virus in which the MIR2911-binding nucleotide sequences of PB2 and NS1 were altered. Importantly, the inhibitory effect of HS decoction on viral replication was abolished by an anti-MIR2911 antagomir, indicating that the physiological concentration of MIR2911 in HS decoction could directly and sufficiently suppress H1N1 viral replication. MIR2911 also inhibited H5N1 and H7N9 viral replication in vitro and in vivo. Strikingly, administration of MIR2911 or HS decoction dramatically reduced mouse mortality caused by H5N1 infection. Our results demonstrate that MIR2911 is the first active component identified in Traditional Chinese Medicine to directly target various IAVs and may represent a novel type of natural product that effectively suppresses viral infection.


Asunto(s)
Virus de la Influenza A/fisiología , Lonicera/genética , MicroARNs/uso terapéutico , Infecciones por Orthomyxoviridae/terapia , ARN de Planta/uso terapéutico , Replicación Viral , Animales , Regulación Viral de la Expresión Génica , Células HEK293 , Humanos , Subtipo H1N1 del Virus de la Influenza A/genética , Subtipo H1N1 del Virus de la Influenza A/fisiología , Subtipo H5N1 del Virus de la Influenza A/genética , Subtipo H5N1 del Virus de la Influenza A/fisiología , Subtipo H7N9 del Virus de la Influenza A/genética , Subtipo H7N9 del Virus de la Influenza A/fisiología , Virus de la Influenza A/genética , Gripe Humana/terapia , Gripe Humana/virología , Ratones , MicroARNs/genética , MicroARNs/farmacocinética , Mutación , Infecciones por Orthomyxoviridae/virología , ARN de Planta/genética , ARN de Planta/farmacocinética
4.
Bioessays ; 36(4): 394-406, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24436255

RESUMEN

If validated, diet-derived foreign microRNA absorption and function in consuming vertebrates would drastically alter our understanding of nutrition and ecology. RNA interference (RNAi) mechanisms of Caenorhabditis elegans are enhanced by uptake of environmental RNA and amplification and systemic distribution of RNAi effectors. Therapeutic exploitation of RNAi in treating human disease is difficult because these accessory processes are absent or diminished in most animals. A recent report challenged multiple paradigms, suggesting that ingested microRNAs (miRNAs) are transferred to blood, accumulate in tissues, and exert canonical regulation of endogenous transcripts. Independent replication of these findings has been elusive, and multiple disconfirmatory findings have been published. In the face of mounting negative results, any additional positive reports must provide the proverbial "extraordinary proof" to support such claims. In this article, we review the evidence for and against a significant role for dietary miRNAs in influencing gene expression, and make recommendations for future studies. Also watch the Video Abstract.


Asunto(s)
Dieta , MicroARNs/farmacocinética , Interferencia de ARN , Vertebrados/genética , Animales , Abejas/genética , Caenorhabditis elegans/genética , Tracto Gastrointestinal/metabolismo , Expresión Génica , Humanos , Intestinos/fisiología , Ratones , MicroARNs/metabolismo , ARN de Planta/farmacocinética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA